Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Multiple Myeloma 27Burkitt Lymphoma 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Neoplasm Metastasis 4Leukemia, Biphenotypic, Acute 4Immunoglobulin Light-chain Amyloidosis 4Smoldering Multiple Myeloma 3Neoplasms 3Lung Neoplasms 3Down Syndrome 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Hodgkin Disease 2Breast Neoplasms 2Brain Neoplasms 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Prostatic Neoplasms 1Plasmacytoma 1Myelodysplastic Syndromes 1Meningioma 1Mastocytosis, Systemic 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Plasma Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 8Tamoxifen 6Standard of Care 4Practice Guidelines as Topic 4Radiotherapy 3Methods 3Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Radiation 2Educational Status 2Early Intervention, Educational 2Counseling 2ruxolitinib 1pembrolizumab 1exemestane 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1abemaciclib 1Watchful Waiting 1Telemedicine 1Taxes 1Tablets 1Surveys and Questionnaires 1Starch 1Reverse Transcriptase Polymerase Chain Reaction 1Ranitidine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Carcinoma In Situ × dexamethasone acetate × 1 year × Clear all
NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Ohio State University Comprehensive Cancer Center

Phase 2/3 Completed
130 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡